| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 12/17/2008 | CN101322809A Ultra-high biomass high activity Chinese medicine preparation series for regenerating biological reaction, activating blood circulation and resolving stasis |
| 12/17/2008 | CN101322790A Wine for freeing channels and preparation thereof |
| 12/17/2008 | CN101322774A Medicament composition with fatigue-resisting function and preparation method and application thereof |
| 12/17/2008 | CN101322763A Specific external-use medicament for treating allergic rhinitis |
| 12/17/2008 | CN101322739A Prescription of Chinese medicine health care capsules mixed with nucleotide and aminoacid and preparing technique |
| 12/17/2008 | CN101322734A Codonopsis lanceolata total saponins with antiinflammatory immunity function and preparation thereof |
| 12/17/2008 | CN101322711A Health care medicament for resisting fatigue and enhancing immunity and preparation thereof |
| 12/17/2008 | CN101322708A Extended release oral dosage composition |
| 12/17/2008 | CN101322556A Tibetan medicine anti-fatigue anoxia-tolerance drink |
| 12/17/2008 | CN101322514A Green tea Ganoderma lucidum drink and preparation method thereof |
| 12/17/2008 | CN100443503C Humanized CTLA-4 single chain antibody and human perforin path formed peptide P34 recombinant immunotoxin |
| 12/17/2008 | CN100443494C 2-phenoxy chromone heteroside compounds and its preparing method and use |
| 12/17/2008 | CN100443474C New pyridazin-3(2h)-one derivatives |
| 12/17/2008 | CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/16/2008 | US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 12/16/2008 | US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 12/16/2008 | US7465553 Psoriasin expression by breast epithelial cells |
| 12/16/2008 | US7465451 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 12/16/2008 | US7465445 Methods of preventing or treating graft versus host reaction by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465444 Methods of suppressing or treating an inflammatory bowel disease by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465437 Delivery of anti-migraine compounds through an inhalation route |
| 12/16/2008 | US7465436 Aerosol for delivery of benzotropine, pergolide, amantadine, deprenyl, or ropinerole, formed by vaporizing the drug that is coated on a solid support and condensing the vapor to form particles containing least 10 % by weight of the drug and less than 5 % by weight of degradation products |
| 12/16/2008 | US7465435 Delivery of beta-blockers through an inhalation route |
| 12/16/2008 | CA2254975C Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/11/2008 | WO2008150525A1 Anti-notch1 nrr antibodies and methods using same |
| 12/11/2008 | WO2008150182A1 Compositions and methods for treatment of anthrax |
| 12/11/2008 | WO2008150181A1 Compositions and methods for treating anthrax exposure associated conditions |
| 12/11/2008 | WO2008149838A1 Novel fractionation product of royal jelly, method for production of the same, and use of the same |
| 12/11/2008 | WO2008149834A1 Pyrimidodiazepinone derivative |
| 12/11/2008 | WO2008149428A1 Therapeutic agent and preventive agent for autoimmune disease, inflammation and nerve disease |
| 12/11/2008 | WO2008149053A1 Bicycl0 [2. 2. 1] he pt- 2-ylamine derivates and their use |
| 12/11/2008 | WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | WO2008148573A2 Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms |
| 12/11/2008 | WO2008148349A1 Use of beta-arrestin 1 for modulating t cell survival and autoimmunity |
| 12/11/2008 | WO2008148247A1 Cyclic analog of thymus pentapeptide, its preparing method and use |
| 12/11/2008 | WO2008130953A3 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands |
| 12/11/2008 | WO2008123800A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles |
| 12/11/2008 | WO2008109852A3 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 12/11/2008 | WO2008106131A3 Combination therapy for treatment of immune disorders |
| 12/11/2008 | WO1999027105A9 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 12/11/2008 | US20080306252 Sulfonamido ether substituted imidazoquinolines |
| 12/11/2008 | US20080306163 such as conjunctivitis via administering (+)-3-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one; phosphodiesterase inhibitors; for topical administration and for use as drops |
| 12/11/2008 | US20080306130 Inhibitors of ubiquitin E1 |
| 12/11/2008 | US20080306124 Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands |
| 12/11/2008 | US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione |
| 12/11/2008 | US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 12/11/2008 | US20080306085 Non-imidazole aryloxyalkylamines |
| 12/11/2008 | US20080306079 External preparation for allergic diseases |
| 12/11/2008 | US20080306075 Pharmaceutical Compositions For Transdermal Delivery |
| 12/11/2008 | US20080306068 Suppression cytokines, tumor necrosis factor |
| 12/11/2008 | US20080306067 Modulators of Chemokine Receptor Activity |
| 12/11/2008 | US20080306065 Metalloproteinase Inhibitors |
| 12/11/2008 | US20080306050 Aminodiazepines as Toll-Like Receptor Modulators |
| 12/11/2008 | US20080306010 Vaccine composition containing irradiated ovalbumin for the prevention and treatment of allergic disease |
| 12/11/2008 | US20080306000 Three-Dimensional Structures of TALL-1 and its Cognate Receptors and Modified Proteins and Methods Related Thereto |
| 12/11/2008 | US20080305997 Modulation Of Cd4+ T Cell Responses By A Tick Saliva Protein, Salp15 And Polypeptides Derived Therefrom |
| 12/11/2008 | US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 12/11/2008 | US20080305995 Royal Jelly Peptide and Composition Containing the Same |
| 12/11/2008 | US20080305117 Kir-Binding Agents and Methods of Use Thereof |
| 12/11/2008 | US20080305116 Anti-Cd154 Antibodies |
| 12/11/2008 | US20080305114 Human antibodies that bind human il-12 and methods for producing |
| 12/11/2008 | US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof |
| 12/11/2008 | US20080305109 Method of passive immunization |
| 12/11/2008 | US20080305092 Methods of treating autoimmune disease via CTLA-4IG |
| 12/11/2008 | US20080305091 Poly-Epitope Peptide Derived from Thymidylate Synthase Having Immunological and Anti-Tumour Activity |
| 12/11/2008 | US20080305090 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times |
| 12/11/2008 | US20080305089 Pharmaceutical Composition for Protection from Allergies and Inflammatory Disorders |
| 12/11/2008 | US20080305079 Myeloid Suppressor Cells, Methods For Preparing Them, and Methods For Using Them For Treating Autoimmunity |
| 12/11/2008 | US20080305078 Soluble Il-17Rc Variant and Uses Thereof |
| 12/11/2008 | US20080305077 Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system |
| 12/11/2008 | US20080305074 Stem cell factor |
| 12/11/2008 | US20080305038 Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells |
| 12/11/2008 | CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | CA2689374A1 Pyrimidodiazepinone derivative |
| 12/11/2008 | CA2687866A1 Anti-notch1 nrr antibodies and methods using same |
| 12/10/2008 | EP2000481A1 High affinity anti-human IgE antibodies |
| 12/10/2008 | EP2000469A2 Acylaminopiperidine compound |
| 12/10/2008 | EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications |
| 12/10/2008 | EP2000144A1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono-and disaccharide-based compounds |
| 12/10/2008 | EP2000136A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 12/10/2008 | EP1999137A1 Synthetic archaeal glycolipid adjuvants |
| 12/10/2008 | EP1999130A1 Pyridopyrimidine derivatives and their use as pde4 inhibitors |
| 12/10/2008 | EP1999107A2 Amine derivatives |
| 12/10/2008 | EP1998804A1 Compositions comprising a recombinant adenovirus and an adjuvant |
| 12/10/2008 | EP1998795A2 Coronin 1 modulators for the treatment of autoimmune and lymphoproliferative disorders and mycobacterial infections |
| 12/10/2008 | EP1998757A1 Milk oligosaccharides for stimulating the immune system |
| 12/10/2008 | EP1511730B1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 12/10/2008 | EP1487410B1 Preparation of sterile stabilized nanodispersions |
| 12/10/2008 | EP1397122B1 Solid immunity adjuvant and vaccine containing the same |
| 12/10/2008 | EP1396487B1 Phenylpyridine carbonyl piperazine derivative |
| 12/10/2008 | EP1379222B1 Orodispersible effervescent tablets |
| 12/10/2008 | EP1289549B1 The use of plant oil-bodies in vaccine delivery systems |
| 12/10/2008 | EP1274450B1 Medical uses of agonsist and antagonists of IL-174 |
| 12/10/2008 | EP1267921B1 Composition and method for the prevention and/or the treatment of der pii allergy |
| 12/10/2008 | EP0972054B1 Enhancement of immune response using targeting molecules |
| 12/10/2008 | CN101321784A Nanobodies and polypeptides against EGFR and IGF-IR |
| 12/10/2008 | CN101321783A 人抗-b7rp1中和抗体 Human anti -b7rp1 neutralizing antibodies |
| 12/10/2008 | CN101321749A Novel vinylogous acids derivatives |
| 12/10/2008 | CN101319247A IL-2 selective agonists and antagonists |
| 12/10/2008 | CN101318017A Vaccine for preventing and/or treating allergic asthma |